News of Note—J&J launches neurovascular business; Olympus to pay $6.6M over superbug outbreak

news of note

> Johnson & Johnson unveiled a new neurovascular business, dubbed Cerenovus, which includes products that the conglomerate's Codman Neuro unit picked up in its acquisitions of Pulsar Vascular and stroke care company Neuravi. Release

> A jury ordered endoscope maker Olympus to fork over $6.6 million in damages to a Seattle hospital. The verdict concludes an eight-week trial surrounding the company's endoscopes and drug-resistant infections. MedCityNews story | Read more

> Roxwood Medical has struck a deal with Abbott to distribute its cardiovascular catheters in the U.S. Release


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.